Chen Tianwu, Zhang Peng, Chen Jiwu, Hua Yinghui, Chen Shiyi
Department of Sports Medicine and Arthroscopy, Huashan Hospital, Shanghai, China.
Sports Medicine Center, Fudan University, Shanghai, China.
Am J Sports Med. 2017 Oct;45(12):2739-2750. doi: 10.1177/0363546517721692. Epub 2017 Sep 11.
The optimal graft choice of anterior cruciate ligament (ACL) reconstruction remains controversial.
To compare the outcomes, especially the long-term cumulative failure rate, of ACL reconstruction using either synthetics with remnant preservation or hamstring autografts (4-strand semitendinosus and gracilis tendons).
Cohort study; Level of evidence, 2.
A total of 133 patients who underwent ACL reconstruction (synthetics: n = 43; hamstring autografts: n = 90) between July 2004 and December 2007 were included. Questionnaires (Tegner activity scale, Lysholm knee scale, and International Knee Documentation Committee [IKDC] subjective form) were completed preoperatively and at 6 months, 1 year, 5 years, and 10 years postoperatively. The Knee injury and Osteoarthritis Outcome Score (KOOS) was additionally applied at 10 years' follow-up. The physical examination was based on the 2000 IKDC form. The manual maximum side-to-side difference (KT-1000 arthrometer), single-hop test, thigh muscle atrophy, and joint degeneration (Kellgren and Lawrence classification) were evaluated. The Kaplan-Meier curve and log-rank test (Mantel-Cox, 95% CI) were used to compare graft survivorship.
Ten years postoperatively, 111 patients were available, with 38 (88.4%) patients (mean age, 27.6 ± 9.3 years; 28 men) with synthetics and 73 (81.1%) patients (mean age, 28.6 ± 8.8 years; 64 men) with hamstring autografts. Among them, 104 patients (synthetics: n = 35 [81.4%]; hamstring autografts: n = 69 [76.7%]) completed subjective evaluations, and 89 patients (synthetics: n = 30 [69.8%]; hamstring autografts: n = 59 [65.6%]) completed objective evaluations. For hamstring autografts and synthetics, the cumulative failure rates were 8.2% and 7.9%, respectively, and the log-rank test demonstrated no significant difference between the 2 Kaplan-Meier survival curves ( P = .910). At 6 months postoperatively, for hamstring autografts and synthetics, the mean Lysholm score was 83.0 ± 7.8 and 88.1 ± 7.5, respectively ( P < .001); the mean IKDC score was 83.8 ± 7.8 and 86.9 ± 4.5, respectively ( P = .036); and the mean Tegner score was 3.7 ± 1.1 and 5.0 ± 1.5, respectively ( P < .001). At 1 year postoperatively, the mean Tegner score was 5.5 ± 1.9 and 6.5 ± 2.0, respectively ( P = .011). No statistically significant difference was observed on other subjective evaluation findings, physical examination findings (overall IKDC grade A: 45.8% of hamstring autografts, 50.0% of synthetics), side-to-side difference (1.5 ± 1.5 mm for synthetics, 2.4 ± 2.1 mm for hamstring autografts), single-hop test findings (grade A: 84.7% of hamstring autografts, 93.3% of synthetics), grade A/B thigh muscle atrophy (88.1% of hamstring autografts, 93.3% of synthetics), ipsilateral radiographic osteoarthritis (55.9% of hamstring autografts, 50.0% of synthetics), and graft survivorship.
In this prospective cohort study, primary ACL reconstruction using either synthetics with remnant preservation or hamstring autografts showed satisfactory outcomes, especially the long-term cumulative failure rate, at 10 years postoperatively. Patient-reported outcomes suggested that symptom relief and restoration of function might occur earlier in those with synthetics.
前交叉韧带(ACL)重建的最佳移植物选择仍存在争议。
比较使用保留残端的合成移植物或腘绳肌自体移植物(4股半腱肌和股薄肌腱)进行ACL重建的效果,尤其是长期累积失败率。
队列研究;证据等级,2级。
纳入2004年7月至2007年12月期间接受ACL重建的133例患者(合成移植物组:n = 43;腘绳肌自体移植物组:n = 90)。术前以及术后6个月、1年、5年和10年完成问卷调查(Tegner活动量表、Lysholm膝关节量表和国际膝关节文献委员会[IKDC]主观表格)。在10年随访时额外应用膝关节损伤和骨关节炎结局评分(KOOS)。体格检查基于2000年IKDC表格。评估手动最大两侧差值(KT - 1000关节测量仪)、单腿跳跃试验、大腿肌肉萎缩和关节退变(Kellgren和Lawrence分级)。使用Kaplan - Meier曲线和对数秩检验(Mantel - Cox,95%CI)比较移植物存活率。
术后10年,111例患者可供评估,其中38例(88.4%)使用合成移植物的患者(平均年龄,27.6±9.3岁;28例男性)和73例(81.1%)使用腘绳肌自体移植物的患者(平均年龄,28.6±8.8岁;64例男性)。其中,104例患者(合成移植物组:n = 35 [81.4%];腘绳肌自体移植物组:n = 69 [76.7%])完成主观评估,89例患者(合成移植物组:n = 30 [69.8%];腘绳肌自体移植物组:n = 59 [65.6%])完成客观评估。对于腘绳肌自体移植物和合成移植物,累积失败率分别为8.2%和7.9%,对数秩检验显示两条Kaplan - Meier生存曲线之间无显著差异(P = 0.910)。术后6个月,对于腘绳肌自体移植物和合成移植物,平均Lysholm评分分别为83.0±7.8和88.1±7.5(P < 0.001);平均IKDC评分为83.8±7.8和86.9±4.5(P = 0.036);平均Tegner评分为3.7±1.1和5.0±1.5(P < 0.001)。术后1年,平均Tegner评分分别为5.5±1.9和6.5±2.0(P = 0.011)。在其他主观评估结果、体格检查结果(总体IKDC A级:腘绳肌自体移植物组45.8%,合成移植物组50.0%)、两侧差值(合成移植物1.5±1.5 mm,腘绳肌自体移植物2.4±2.1 mm)、单腿跳跃试验结果(A级:腘绳肌自体移植物组84.7%,合成移植物组93.3%)、A级/B级大腿肌肉萎缩(腘绳肌自体移植物组88.1%,合成移植物组93.3%)、同侧影像学骨关节炎(腘绳肌自体移植物组55.9%,合成移植物组50.0%)和移植物存活率方面未观察到统计学显著差异。
在这项前瞻性队列研究中,使用保留残端的合成移植物或腘绳肌自体移植物进行初次ACL重建在术后10年显示出令人满意的效果,尤其是长期累积失败率。患者报告的结果表明,使用合成移植物的患者症状缓解和功能恢复可能更早出现。